Dear editor,Acute massive pulmonary embolism(PE) is a common life-threatening disease with high mortality of up to 30%–50%.[1,2]Potential heterogeneous reasons for PE remain controversial, and its treatment strategie...Dear editor,Acute massive pulmonary embolism(PE) is a common life-threatening disease with high mortality of up to 30%–50%.[1,2]Potential heterogeneous reasons for PE remain controversial, and its treatment strategies mainly include antithrombotics, fibrinolytics, and embolectomy.展开更多
基金This work was partly supported by grant from the Youth Fund of National Natural Science Foundation of China(81800441)Start-up Fund from Shanghai Fourth People’s Hospital Affiliated to Tongji University,Clinical Science and Technology Innovation Project of Shanghai Hospital Development Center,Construction and Application of Emergency and Critical Care Integrated Management Mode(SHDC22021211).
文摘Dear editor,Acute massive pulmonary embolism(PE) is a common life-threatening disease with high mortality of up to 30%–50%.[1,2]Potential heterogeneous reasons for PE remain controversial, and its treatment strategies mainly include antithrombotics, fibrinolytics, and embolectomy.
